133 related articles for article (PubMed ID: 37983010)
1. Discovery of New
Pan Z; Zhou C; Bai X; Wang F; Hong J; Fang JY; Huang Y; Sheng C
J Med Chem; 2023 Dec; 66(23):15699-15714. PubMed ID: 37983010
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent natural product higenamine derivatives as novel Anti-Fusobacterium nucleatum agents.
Su S; Bu Q; Bai X; Huang Y; Wang F; Hong J; Fang JY; Wu S; Sheng C
Bioorg Chem; 2023 Sep; 138():106586. PubMed ID: 37178651
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
5. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of Intestinal
Peng BJ; Cao CY; Li W; Zhou YJ; Zhang Y; Nie YQ; Cao YW; Li YY
Chin Med J (Engl); 2018 Jun; 131(11):1349-1356. PubMed ID: 29786050
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
[TBL] [Abstract][Full Text] [Related]
9.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
10. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.
Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine may promote the progression of
Du X; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Hu Q; Tian Q; Liang L; Zhao X; Li J; Zhao M; Fu X
Virulence; 2024 Dec; 15(1):2350904. PubMed ID: 38725098
[No Abstract] [Full Text] [Related]
13. Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments.
Chen J; Zhang P; Zhao Y; Zhao J; Wu X; Zhang R; Cha R; Yao Q; Gao Y
Sci Adv; 2022 Nov; 8(45):eadd2789. PubMed ID: 36351016
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
15. The Fruits of
Lin LT; Shi YC; Choong CY; Tai CJ
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279421
[TBL] [Abstract][Full Text] [Related]
16. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Kumar A; Thotakura PL; Tiwary BK; Krishna R
BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
[TBL] [Abstract][Full Text] [Related]
17.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
18. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis.
Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X
Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553
[TBL] [Abstract][Full Text] [Related]
19. Colon Cancer-Associated
Abed J; Maalouf N; Manson AL; Earl AM; Parhi L; Emgård JEM; Klutstein M; Tayeb S; Almogy G; Atlan KA; Chaushu S; Israeli E; Mandelboim O; Garrett WS; Bachrach G
Front Cell Infect Microbiol; 2020; 10():400. PubMed ID: 32850497
[No Abstract] [Full Text] [Related]
20. Fabrication of hyaluronic acid-inulin coated Enterococcus faecium for colon-targeted delivery to fight Fusobacterium nucleatum.
Zhu P; Meng L; Shu Y; Xu Y; Liu W; Bi Y; Xu J; Meng L; Li Y
Carbohydr Polym; 2024 Apr; 329():121797. PubMed ID: 38286561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
